Interleukin 6 Promotes Endometrial Cancer Growth Through an Autocrine Feedback Loop Involving ERK–NF-κB Signaling Pathway

Qi Che,Bin-Ya Liu,Fang-Yuan Wang,Yin-Yan He,Wen Lu,Yun Liao,Wei Gu,Xiao-Ping Wan

DOI: https://doi.org/10.1016/j.bbrc.2014.02.080

IF: 3.1

2014-01-01

Biochemical and Biophysical Research Communications

Abstract:Interleukin (IL)-6 as an inflammation factor, has been proved to promote cancer proliferation in several human cancers. However, its role in endometrial cancer has not been studied clearly. Previously, we demonstrated that IL-6 promoted endometrial cancer progression through local estrogen biosynthesis. In this study, we proved that IL-6 could directly stimulate endometrial cancer cells proliferation and an autocrine feedback loop increased its production even after the withdrawal of IL-6 from the medium. Next, we analyzed the mechanism underlying IL-6 production in the feedback loop and found that its production and IL-6-stimulated cell proliferation were effectively blocked by pharmacologic inhibitors of nuclear factor-kappa B (NF-kappa B) and extra-cellular signal-regulated kinase (ERK). Importantly, activation of ERK was upstream of the NE-kappa B pathways, revealing the hierarchy of this event. Finally, we used an orthotopic nude endometrial carcinoma model to confirm the effects of IL-6 on the tumor progression. Taken together, these data indicate that IL-6 promotes endometrial carcinoma growth through an expanded autocrine regulatory loop and implicate the ERK-NF-kappa B pathway as a critical mediator of IL-6 production, implying IL-6 to be an important therapeutic target in endometrial carcinoma. (c) 2014 Elsevier Inc. All rights reserved.